pharmaphorum5d
GSK says Nucala hits the target in new COPD trial
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...
pharmaphorum3d
GSK's Nucala gains US use in rare autoimmune disease
GlaxoSmithKline’s Nucala (mepolizumab) has gained a new FDA approval for the rare autoimmune disease eosinophilic granulomatosis with polyangiitis (EGPA). Nucala, an interleukin-5 (IL-5 ...
Los Angeles Times1d
High School Sports - Los Angeles Times
High school basketball: Scores for boys’ and girls’ games across the Southland on Wednesday, Feb. 12. High school basketball: Scores for boys’ and girls’ games across the Southland on ...
Multiple Sclerosis News Today5d
MS patients highly satisfied with Sensoready autoinjector pen
Nearly all adults with relapsing forms of multiple sclerosis (MS) said they are highly satisfied with the Sensoready autoinjector pen to self-administer Kesimpta (ofatumumab), according to a ...
Los Angeles Times3d
Real Estate - Los Angeles Times
A $450-million residential tower has been proposed on the eastern tip of Beverly Hills. Millennium Partners Los Angeles said the 34-story high-rise would be called the Eastern.